Our Mission
Imagia’s mission is to leverage advances in artificial intelligence and accelerate the advent of accessible personalized medicine.
We believe that synergies between academia, institutions and commercial partners are a critical success factor in the quest towards precision medicine.
Our Story
Our co-founder Alexandre Le Bouthillier wanted to turn his personal loss to cancer into something positive. He founded Imagia with his long-time friend Nicolas Chapados by combining their extensive knowledge of AI and optimization, learned in their previous successful venture, to improve the future of medicine.
The pair, in collaboration with Professor Yoshua Bengio, the world-renowned co-father of deep learning, recruited a team of entrepreneurs, research scientists, developers, and clinical experts. They began exploring applications in computer vision and the quantitative mapping of clinical information to bring the power of deep learning to digitized health data and the company Imagia was born.
Geralyn Ochab
Anne-Marie Guertin
Florent Chandelier
Shelley Epstein
Kam Kafi
2019
January 2019
Imagia opens new office located in the AI epicenter of Montreal in the MILA building
May 2019
Federal Government Awards $49M to Imagia and the Terry Fox Research Institute led Consortium to Accelerate Medical Breakthroughs through the Digital Health and Discovery Platform (DHDP)
December 2019
Imagia Partners with Top US and Canadian Hospitals to Facilitate AI Accelerated Healthcare Discoveries
2018
February 2018
Imagia enters into a partnership agreement with Sciences In Vivo and the Institute for Research in Immunology and Cancer (IRIC).
March 2018
The Government of Quebec, through the BioMed Propulsion program, grants Imagia a $3 million loan.
May 2018
Imagia enters into a collaborative agreement with Olympus, through AI4GI, for the exclusive development of an AI solution for real-time clinical decision support during screening and colonoscopy surveillance procedures.
November 2018
Google mentioned Imagia in the annual report of its economic impact in Canada.
Imagia concludes a collaborative agreement with Christie Innomed.
December 2018
Imagia receives funding from Canada Economic Development for Quebec Regions (CED).
2017
February 2017
Imagia ranks as one of the world’s best AI start-ups transforming healthcare according to CBInsights.
November 2017
Imagia acquires Cadens Medical Imaging Inc.
2016
December 2016
Series A financing led by BDC Healthcare Venture Fund and joined by Fidelity Investments Canada ULC.
2015
January 2015
Long-time friends Alexandre Le Bouthillier and Nicolas Chapados launch Imagia, supported by one of the three fathers of deep learning, Prof Yoshua Bengio.
Please complete the form in order to direct your request to the appropriate department, and we will reach out as soon as possible.